Soluble P-selectin and proinflammatory cytokines in patients with polygenic type IIa hypercholesterolemia

被引:0
|
作者
Ferroni, P
Basili, S
Vieri, M
Martini, F
Labbadia, G
Bellomo, A
Gazzaniga, PP
Cordova, C
Alessandri, C
机构
[1] Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00161 Rome, Italy
[2] Univ Roma La Sapienza, Dept Med Therapy, I-00161 Rome, Italy
[3] Univ Roma La Sapienza, Ist Terapia Med Sistemat, I-00161 Rome, Italy
关键词
hypercholesterolemia; P-selectin; cytokines; IL-6; IL-1; beta; prothrombin fragment 1+2; fibrinogen;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma soluble P-selectin (sP-selectin), beta-thromboglobulin (beta-TG), von Willebrand Factor (vWF), prothrombin factor 1+2 (F1+2), IL-6 and IL-1 beta levels were analyzed in 35 consecutive patients with polygenic type IIa hypercholesterolemia (HC) and 35 age- and sex-matched healthy subjects. sP-selectin (p < 0.005), beta-TG (p < 0.05) and IL-1 beta (p < 0.02) levels were higher in HC patients than healthy subjects whereas no significant difference was observed for vWF. sP-selectin directly correlated with beta-TG (p < 0.05) and IL-1 beta levels (p < 0.005), but not with the other variables analyzed. A direct correlation was observed between F1+2 and IL-6 (p < 0.05), total cholesterol (p < 0.05) or LDL cholesterol (p < 0.05). We conclude that HC is associated with an increase of plasma sP-selectin levels, and that sP-selectin may be considered as a marker of in vivo platelet activation in type IIa polygenic HC. The correlations observed among the variables analyzed in the study suggest that proinflammatory cytokines might play a role in the prothrombotic state often associated with HC. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [1] Bone marrow megakaryocytes, soluble P-selectin and thrombopoietic cytokines in multiple myeloma patients
    Lemancewicz, Dorota
    Bolkun, Lukasz
    Mantur, Maria
    Semeniuk, Janusz
    Kloczko, Janusz
    Dzieciol, Janusz
    PLATELETS, 2014, 25 (03) : 181 - 187
  • [2] Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease
    Carter, AM
    Anagnostopoulou, K
    Mansfield, MW
    Grant, PJ
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (08) : 1718 - 1723
  • [3] Soluble P-selectin in diabetes
    Jilma, B
    Fijnheer, R
    Blann, AD
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (03) : 474 - 474
  • [4] Soluble P-selectin concentration in patients with colorectal cancer
    Dymicka-Piekarska, V
    Butkiewicz, A
    Matowicka-Karna, J
    Kemona, H
    NEOPLASMA, 2005, 52 (04) : 297 - 301
  • [5] Levels of Soluble P-Selectin in Patients With Unstable Angina
    Jianting Doug
    Xiaofei Jiang
    Huayu Huang
    Ganxiong Liang MD
    中国介入心脏病学杂志, 1998, (04) : 190 - 190
  • [6] Soluble P-selectin in the plasma of patients with acute stroke
    Tanahashi, N
    Fukuuchi, Y
    Tomita, M
    Takao, S
    Itoh, D
    Handa, M
    JOURNAL OF VASCULAR RESEARCH, 1998, 35 : 49 - 49
  • [7] Increased levels of soluble P-selectin in hypercholesterolemic patients
    Davì, G
    Romano, M
    Mezzetti, A
    Procopio, A
    Iacobelli, S
    Antidormi, T
    Bucciarelli, T
    Alessandrini, P
    Cuccurullo, F
    Bon, GB
    CIRCULATION, 1998, 97 (10) : 953 - 957
  • [8] Increased levels of soluble P-selectin in hypercholesterolemic patients
    Romano, M
    Mezzetti, A
    Procopio, A
    Iacobelli, S
    Costantini, F
    Bucciarelli, T
    Alessandrini, P
    Bon, GB
    Cuccurullo, F
    Davi, G
    CIRCULATION, 1997, 96 (08) : 934 - 934
  • [9] Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease
    Fägerstam, JP
    Whiss, PA
    Ström, M
    Andersson, RGG
    INFLAMMATION RESEARCH, 2000, 49 (09) : 466 - 472
  • [10] Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease
    J.P. Fägerstam
    P.A. Whiss
    M. Ström
    R.G.G. Andersson
    Inflammation Research, 2000, 49 : 466 - 472